H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Novel H1N1 influenza raises parents' awareness and concern about seasonal influenza

Novel H1N1 influenza raises parents' awareness and concern about seasonal influenza

Poor readiness by many hospitals to tackle H1N1 pandemic; RNs step up protest

Poor readiness by many hospitals to tackle H1N1 pandemic; RNs step up protest

California's community hospitals launch public education and media campaign on H1N1

California's community hospitals launch public education and media campaign on H1N1

WHO recommends antivirals for patients with symptoms of both H1N1, pneumonia

WHO recommends antivirals for patients with symptoms of both H1N1, pneumonia

Experts: Treat swine flu quickly, even without verification

Experts: Treat swine flu quickly, even without verification

Vaccinations and preventative hygiene routines can help protect families from H1N1

Vaccinations and preventative hygiene routines can help protect families from H1N1

Pork consumption is safe, says USDA scientists

Pork consumption is safe, says USDA scientists

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

New scientific journal from Elsevier

New scientific journal from Elsevier

CytoSorb human clinical trials nearing completion

CytoSorb human clinical trials nearing completion

Inaccurate body temperature readings can harm the entire health care system

Inaccurate body temperature readings can harm the entire health care system

Government closely monitors swine flu vaccine

Government closely monitors swine flu vaccine

Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics

Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics

International human migration needs to be factored into infectious disease policy

International human migration needs to be factored into infectious disease policy

FDA urges consumers to exercise care on online H1N1 drug products

FDA urges consumers to exercise care on online H1N1 drug products

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

CVS Caremark's seasonal flu shot clinics to run through October 22

CVS Caremark's seasonal flu shot clinics to run through October 22

HHS Secretary to address ASTHO to discuss critical national public health issues

HHS Secretary to address ASTHO to discuss critical national public health issues

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.